Track topics on Twitter Track topics that are important to you
3V SourceOne ("3VS1") is a next generation venture capital partnership based in Silicon Valley and Singapore specializing in investments in emerging companies developing cutting-edge enabling technologies in the communications, IT and the life sciences sectors.
3VS1 was founded in Q3 2000 by Michael Wu, Jeffrey Khoo and Kim Seng Tan. The three founding General Partners combine over 45 years of venture capital investment, entrepreneurial and operational experience in technology companies.
The partners formerly managed the U.S. and China portfolios of venture funds totaling US$125 million. They also led the organization of a technology fund anchored by reputable financial institutions in the US, Singapore and Taiwan
13888 Trinity Avenue
United States of America
MELVILLE, N.Y., June 27, 2017 /PRNewswire/ -- Henry Schein, Inc. (Nasdaq:HSIC) announced today that it has settled litigation with SourceOne Dental Inc. that will result in a $0.04 per share...
3V SourceOne ("3VS1") is a next generation venture capital partnership based in Silicon Valley and Singapore specializing in investments in emerging companies developing cutting-edge enabling technolo...
We have published hundreds of 3V SourceOne news stories on BioPortfolio along with dozens of 3V SourceOne Clinical Trials and PubMed Articles about 3V SourceOne for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of 3V SourceOne Companies in our database. You can also find out about relevant 3V SourceOne Drugs and Medications on this site too.
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...